JPRN-UMIN000012618已完成2 期
Efficacy and safety of S-1 plus oxaliplatin (C-SOX) as adjuvant chemotherapy for Stage III colon cancer. - Efficacy and safety of S-1 plus oxaliplatin (C-SOX) as adjuvant chemotherapy for Stage III colon cancer.(KSCC1303)
Kyushu Study group of Clinical Cancer(KSCC)0 个研究点目标入组 85 人开始时间: 2013年12月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 85
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of the severe hypersensitivity 2) Active other malignancies 3) Sensory neuropathy >= Grade 1 4) Diarrhea >= Grade 2 5) Active infections 6) History of mental disorder, central nerve disorder 7) Serious complication 8) Blood transfusion or hemopoietic factors (e.g. G-CSF) within 14 days 9) Pleural effusion, peritoneal fluid that needs treatment 10) Hemorrhagic diathesis, coagulation disorder 11) Patients who need flucytosine, phenytoin or warfarin potassium 12) Requiring steroid drug 13) Pregnant or lactating woman and man who hope for Partner's pregnant 14) Positive for HBs antigen and HCV antibody 15) Investigator's judgement
研究者
相似试验
已完成
1 期
A Phase I/II Study of S-1 and Oxaliplatin Combined With Radiation for Preoperative Locally Advanced Rectal CarcinomaColorectal CancerJPRN-UMIN000017450Japan Clinical Cancer Research Organization45
已完成
1 期
Phase l and Phase ll Study of S-1+oxaliplatin (SOX)+cetuximab as first Line therapy in metastatic colorectal cancer with EGFR-detectable and KRAS wild typeMetastatic colorectal cancerJPRN-UMIN000007022Japan Clinical Cancer Research Organization56
Unknown
1 期
SOX as Adjuvant Chemotherapy for Resectable Gastric CancerGastric CancerNCT01542294Chinese Academy of Medical Sciences71
已完成
2 期
Phase II study of S-1 plus oxaliplatin (130 mg/m2, every 3 weeks) for advanced gastric cancerJPRN-UMIN000016973Shizuoka Cancer Center25
Unknown
1 期
Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant SettingRectal CarcinomaNCT01227239Japan Clinical Cancer Research Organization45